水產養殖疫苗市場規模、佔有率、成長分析（按產品、給藥途徑、應用和地區分類）- 產業預測，2025-2032 年

2023 年全球水產養殖疫苗市場規模為 2.146 億美元，預計將從 2024 年的 2.3091 億美元成長到 2032 年的 4.149 億美元，預測期內（2025-2032 年）的複合年成長率為 7.6%。

由於水產養殖物種細菌和病毒疾病的增加，全球水產養殖疫苗市場預計將顯著成長。這種成長正在促進創新疫苗的生產和採用，例如希臘的 Icthiovac VR/PD，該疫苗於 2018 年 3 月推出，用於對抗弧菌病和巴氏桿菌症。水產養殖新型疫苗的開發進一步推動了市場的擴大。預計向 DNA 和重組疫苗的轉變，加上消費者對海鮮的需求不斷成長，將推動這一成長。尤其是像碩騰這樣的公司報告銷售額成長了 13%，凸顯出該行業重點向必需品的轉移。 2016年至2019年間，水產養殖業記錄了219多例感染疾病案例，對有效疫苗接種解決方案的需求持續成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究

水產養殖疫苗市場規模（依產品）

• 市場概況
• 減毒活病毒疫苗
• 去活化疫苗
• 次單位疫苗
• DNA疫苗
• 重組疫苗

按給藥途徑分類的水產養殖疫苗市場規模

• 市場概況
• 口服
• 注射
• 浸塗和噴塗

水產養殖疫苗市場規模（依應用）

• 市場概況
• 細菌
• 病毒性的
• 寄生蟲
• 其他

水產養殖疫苗的市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Zoetis Inc.（USA）
• Merck Animal Health（USA）
• Elanco Animal Health（USA）
• Hipra（Spain）
• Ceva Sante Animale（France）
• Vaxxinova（Netherlands）
• AquaBounty Technologies（USA）
• Benchmark Holdings plc（UK）
• Pharmaq AS（Norway）
• Phibro Animal Health Corporation（USA）
• KBNP（South Korea）
• Nisseiken Co., Ltd.（Japan）
• Kyoto Biken Laboratories, Inc.（Japan）
• Cavac（China）
• VETERQUIMICA SA（Spain）
• CSL Limited（Australia）
• Emergent BioSolutions, Inc.（USA）
• Johnson & Johnson（USA）
• AstraZeneca plc（UK）
• Sanofi SA（France）

結論和建議

Global Aquaculture Vaccine Market size was valued at USD 214.6 million in 2023 and is poised to grow from USD 230.91 million in 2024 to USD 414.9 million by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).

The global aquaculture vaccine market is poised for significant growth, driven by escalating bacterial and viral illnesses among aquaculture species. This rise is prompting increased production and adoption of innovative vaccines, such as Greece's Icthiovac VR/PD, launched in March 2018 to combat Vibriosis and Pasteurellosis. Enhanced funding for the development of novel aquaculture vaccines further supports market expansion. The shift towards DNA and recombinant vaccines, coupled with growing consumer demand for aquatic food products, is expected to fuel this growth. Notably, companies like Zoetis reported a 13% increase in sales, highlighting the industry's shift in focus toward essential goods. With over 219 infectious disease cases documented in the aquaculture sector from 2016 to 2019, the demand for effective vaccination solutions continues to rise.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aquaculture Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aquaculture Vaccine Market Segmental Analysis

Global Aquaculture Vaccine Market is segmented by Product, Route of Administration, Application and region. Based on Product, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines and Recombinant Vaccines. Based on Route of Administration, the market is segmented into Oral, Injected and Immersion & Spray. Based on Application, the market is segmented into Bacterial, Viral, Parasitic and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aquaculture Vaccine Market

The global aquaculture vaccine market is witnessing significant growth driven by a surge in disease outbreaks affecting seafood. Notably, incidents like the Pasteurella Skyensis outbreak in 2017, which led to the loss of approximately 125,000 salmon at farms in the Isle of Lewis, underscore the urgency for effective vaccination. Rising fish mortality rates, coupled with a growing demand for animal protein, are also propelling the need for aquaculture vaccines. Furthermore, government initiatives promoting vaccination programs and increased adoption of these vaccines in both developed and developing nations are stimulating market expansion. The global trade of aquaculture species is expected to provide additional momentum to the aquaculture vaccine market throughout the forecast period.

Restraints in the Global Aquaculture Vaccine Market

The global aquaculture vaccine market faces several constraints that may hinder its growth, primarily due to the challenges associated with handling and administering vaccines. The development of low-cost adjuvants and antigens that comply with environmental and regulatory standards can significantly affect market share, leading to reduced vaccine sales. Additionally, the requirement for highly skilled personnel to properly administer these vaccines complicates the process. Handling concerns also pose risks, including the potential for fungal infections during the vaccination process, further impeding the market's expansion and limiting the adoption of aquaculture vaccines in the industry.

Market Trends of the Global Aquaculture Vaccine Market

The Global Aquaculture Vaccine market is poised for significant growth, driven by technological advancements and an increasing incidence of aquaculture-related diseases. The rise in public-private partnerships focused on research and development fosters innovation, while enhanced diagnostic and therapeutic options in developing regions bolster product offerings. Additionally, rising per capita healthcare spending further propels market expansion. The emergence of strategic alliances and heightened internet connectivity also contribute to the sector's dynamism. Concerns regarding zoonotic diseases and their transmission from aquatic animals to humans are underscoring the urgency of advancing vaccine solutions, thereby solidifying the market's upward trajectory through 2023 and beyond.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Aquaculture Vaccine Market Size by Product & CAGR (2025-2032)

• Market Overview
• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

Global Aquaculture Vaccine Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Injected
• Immersion & Spray

Global Aquaculture Vaccine Market Size by Application & CAGR (2025-2032)

• Market Overview
• Bacterial
• Viral
• Parasitic
• Others

Global Aquaculture Vaccine Market Size & CAGR (2025-2032)

• North America (Product, Route of Administration, Application)
  • US
  • Canada
• Europe (Product, Route of Administration, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Route of Administration, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Route of Administration, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Route of Administration, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Zoetis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hipra (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxxinova (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AquaBounty Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benchmark Holdings plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmaq AS (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KBNP (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nisseiken Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoto Biken Laboratories, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cavac (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VETERQUIMICA SA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations